{"slideshow_credits": null, "snippet": "That this high-water mark is justified by its tax workaround is a sign that the two-year boom of extraordinary corporate deals is reaching its conclusion.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Rob", "role": "reported", "lastname": "COX", "rank": 1, "organization": ""}], "original": "By ROB COX"}, "web_url": "http://www.nytimes.com/2015/12/02/business/dealbook/pfizers-deal-for-allergan-is-a-dubious-milestone.html", "lead_paragraph": "That this high-water mark is justified by its tax workaround is a sign that the two-year boom of extraordinary corporate deals is reaching its conclusion.", "headline": {"main": "Pfizer\u2019s Deal for Allergan Is a Dubious Milestone", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "565e0f2538f0d8640ffa0919", "word_count": "875", "multimedia": [{"height": 126, "url": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 443, "url": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "443"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/24/business/db-pfizerviews-web1/db-pfizerviews-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Corporate Taxes", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}